Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P08235: Variant p.Leu769Pro

Mineralocorticoid receptor
Gene: NR3C2
Feedback?
Variant information Variant position: help 769 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Leucine (L) to Proline (P) at position 769 (L769P, p.Leu769Pro). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Similar physico-chemical property. Both residues are medium size and hydrophobic. The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In PHA1A. Any additional useful information about the variant.


Sequence information Variant position: help 769 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 984 The length of the canonical sequence.
Location on the sequence: help IVYAGYDSSKPDTAENLLST L NRLAGKQMIQVVKWAKVLPG The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         IVYAGYDSSKPDTAENLLSTLNRLAGKQMIQVVKWAKVLPG

Mouse                         IVYAGYDNSKPDTAESLLSTLNRLAGKQMIQVVKWAKVLPG

Rat                           TVYAGYDNSKPDTAESLLSTLNRLAAKQMIQVVKWAKVLPG
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 984 Mineralocorticoid receptor
Domain 726 – 964 NR LBD
Binding site 770 – 770
Binding site 770 – 770
Binding site 770 – 770
Binding site 776 – 776
Binding site 776 – 776
Binding site 776 – 776
Alternative sequence 672 – 788 Missing. In isoform 4.
Alternative sequence 707 – 984 Missing. In isoform 2.
Mutagenesis 767 – 767 S -> N. Loss of transcription transactivation.
Mutagenesis 767 – 767 S -> Q. Strong decrease of transcription transactivation.
Mutagenesis 770 – 770 N -> ADHQST. Abolishes aldosterone binding and transcription transactivation.
Mutagenesis 776 – 776 Q -> A. Reduces aldosterone binding and transcription transactivation.
Mutagenesis 782 – 782 K -> E. Decreased coactivator binding.
Mutagenesis 785 – 785 K -> E. Loss of coactivator binding.
Helix 762 – 785



Literature citations
Mineralocorticoid receptor mutations are the principal cause of renal type 1 pseudohypoaldosteronism.
Pujo L.; Fagart J.; Gary F.; Papadimitriou D.T.; Claes A.; Jeunemaitre X.; Zennaro M.-C.;
Hum. Mutat. 28:33-40(2007)
Cited for: VARIANTS PHA1A SER-645; SER-659; SER-759; PRO-769; LYS-770; PRO-805 AND ARG-815;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.